2024-07-16 08:10:00 ET
Summary
- Stock market investing is not a zero-sum game, offering long-term potential for growth and income when it comes to highly undervalued stocks.
- Bristol Myers Squibb stock is undervalued, with strong revenue growth, profitability, and a promising drug pipeline.
- BMY presents a high conviction buy opportunity for value and income investors, with potential for future growth and acquisitions.
Stock market investing is sometimes referred to as a giant casino, in which day to day price movements are hard to predict, due to the multitude of variables and external events that can influence prices....
Read the full article on Seeking Alpha
For further details see:
Bristol Myers Squibb: The More It Drops, The More I Buy